268 related articles for article (PubMed ID: 28898443)
21. Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors.
Hamza A; Sirohi D; Smith SC; Amin MB
Adv Anat Pathol; 2021 Nov; 28(6):396-407. PubMed ID: 34561376
[TBL] [Abstract][Full Text] [Related]
22. Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma.
Kiyozawa D; Kohashi K; Takamatsu D; Iwasaki T; Shibata D; Tomonaga T; Tateishi Y; Eto M; Kinjo M; Nishiyama K; Taguchi K; Oshiro Y; Kuboyama Y; Furuya M; Oda Y
Hum Pathol; 2022 Jun; 124():36-44. PubMed ID: 35306021
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome).
Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K
Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337
[TBL] [Abstract][Full Text] [Related]
24. Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma.
Mannan R; Wang X; Bawa PS; Chugh S; Chinnaiyan AK; Rangaswamy R; Zhang Y; Cao X; Smith SC; Trpkov K; Williamson SR; Sangoi AR; Mohanty S; McKenney JK; Gupta S; Magi-Galluzzi C; Argani P; Osunkoya AO; Chinnaiyan AM; Dhanasekaran SM; Mehra R
Hum Pathol; 2023 Apr; 134():102-113. PubMed ID: 36581128
[TBL] [Abstract][Full Text] [Related]
25. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
[TBL] [Abstract][Full Text] [Related]
26. [Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis].
Wang Y; Hou MY; Fu Y; Meng K; Wu HY; Chen J; Xu YM; Shi J; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):358-363. PubMed ID: 36973196
[No Abstract] [Full Text] [Related]
27. Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening.
Siegler L; Erber R; Burghaus S; Brodkorb T; Wachter D; Wilkinson N; Bolton J; Stringfellow H; Haller F; Beckmann MW; Hartmann A; Agaimy A
Virchows Arch; 2018 May; 472(5):789-796. PubMed ID: 29332133
[TBL] [Abstract][Full Text] [Related]
28. Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations: Molecular Analysis Supports an Expanding Clinicopathologic Spectrum.
Palsgrove DN; Li Y; Pratilas CA; Lin MT; Pallavajjalla A; Gocke C; De Marzo AM; Matoso A; Netto GJ; Epstein JI; Argani P
Am J Surg Pathol; 2018 Sep; 42(9):1166-1181. PubMed ID: 29975249
[TBL] [Abstract][Full Text] [Related]
29. Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients.
Fuchs TL; Maclean F; Turchini J; Vargas AC; Bhattarai S; Agaimy A; Hartmann A; Kao CS; Ellis C; Bonert M; Leroy X; Kunju LP; Schwartz L; Matsika A; Williamson SR; Rao P; Divatia M; Guarch R; Algaba F; Balancin ML; Zhou M; Samaratunga H; da Cunha IW; Brimo F; Ryan A; Clouston D; Aron M; O'Donnell M; Chan E; Hirsch MS; Moch H; Pang CY; Wah C; Yin W; Perry-Keene J; Yilmaz A; Chou A; Clarkson A; van der Westhuizen G; Morrison E; Zwi J; Hes O; Trpkov K; Gill AJ
Mod Pathol; 2022 Jun; 35(6):836-849. PubMed ID: 34949766
[TBL] [Abstract][Full Text] [Related]
30. A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.
Yakirevich E; Ali SM; Mega A; McMahon C; Brodsky AS; Ross JS; Allen J; Elvin JA; Safran H; Resnick MB
Am J Surg Pathol; 2015 Jun; 39(6):858-63. PubMed ID: 25724004
[TBL] [Abstract][Full Text] [Related]
31. Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma.
Mehra R; Vats P; Cao X; Su F; Lee ND; Lonigro R; Premkumar K; Trpkov K; McKenney JK; Dhanasekaran SM; Chinnaiyan AM
Eur Urol; 2018 Oct; 74(4):483-486. PubMed ID: 29941307
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic Classification of Renal Cell Carcinoma in Patients ≤40 Years Old From Peru.
Kamanda S; Huanca-Amesquita L; Milla E; Argani P; Epstein JI
Int J Surg Pathol; 2024 Feb; 32(1):35-45. PubMed ID: 37062985
[TBL] [Abstract][Full Text] [Related]
33. Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration.
Muller M; Guillaud-Bataille M; Salleron J; Genestie C; Deveaux S; Slama A; de Paillerets BB; Richard S; Benusiglio PR; Ferlicot S
Mod Pathol; 2018 Jun; 31(6):974-983. PubMed ID: 29410489
[TBL] [Abstract][Full Text] [Related]
34. Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report.
Chan MMY; Barnicoat A; Mumtaz F; Aitchison M; Side L; Brittain H; Bates AWH; Gale DP
BMC Med Genet; 2017 Jul; 18(1):79. PubMed ID: 28747166
[TBL] [Abstract][Full Text] [Related]
35. [Succinate dehydrogenase-deficient renal cell carcinoma:a clinicopathological, ultrastructural and molecular analysis].
Wang XT; Wang X; Zhang RS; Cheng K; Xia QY; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):12-16. PubMed ID: 34979747
[No Abstract] [Full Text] [Related]
36. Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases.
Pivovarčíková K; Martínek P; Trpkov K; Alaghehbandan R; Magi-Galluzzi C; Mundo EC; Berney D; Suster S; Gill A; Rychlý B; Michalová K; Pitra T; Hora M; Michal M; Hes O
Cesk Patol; 2019; 55(4):244-249. PubMed ID: 31842557
[TBL] [Abstract][Full Text] [Related]
37. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
38. Multidetector CT Characteristics of Fumarate Hydratase-Deficient Renal Cell Carcinoma and Papillary Type II Renal Cell Carcinoma.
Yang L; Li XM; Hu YJ; Zhang MN; Yao J; Song B
Korean J Radiol; 2021 Dec; 22(12):1996-2005. PubMed ID: 34668351
[TBL] [Abstract][Full Text] [Related]
39. Eosinophilic solid and cystic renal cell carcinoma and renal cell carcinomas with TFEB alterations: a comparative study.
Lobo J; Rechsteiner M; Helmchen BM; Rupp NJ; Weber A; Moch H
Histopathology; 2022 Jul; 81(1):32-43. PubMed ID: 35403742
[TBL] [Abstract][Full Text] [Related]
40. Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases.
Tretiakova MS
Hum Pathol; 2018 Oct; 80():65-75. PubMed ID: 29885406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
